Get Live Data

Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,609.00
Bid: 1,608.50
Ask: 1,609.00
Change: -7.50 (-0.46%)
Spread: 0.50 (0.031%)
Open: 1,619.50
High: 1,622.50
Low: 1,606.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'

Mon, 13th May 2024 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

----------

FTSE 100

----------

Bank of America cuts BAE Systems to 'neutral' (buy) - price target 1,425 (1,385) pence

----------

JPMorgan cuts Ocado price target to 350 (600) pence - 'neutral'

----------

Berenberg raises Aviva price target to 572 (550) pence - 'buy'

----------

Barclays raises National Grid price target to 1,365 (1,320) pence - 'overweight'

----------

UBS raises National Grid price target to 1,240 (1,210) pence - 'buy'

----------

Barclays raises Smurfit Kappa price target to 4,500 (3,830) pence - 'overweight'

----------

Barclays raises Mondi price target to 1,380 (1,350) pence - 'underweight'

----------

Citigroup cuts Mondi to 'neutral' - price target 1,700 pence

----------

RBC raises Anglo American price target to 3,100 (2,300) pence - 'outperform'

----------

Jefferies raises GSK price target to 2,100 (1,950) pence - 'buy'

----------

UBS cuts Rightmove price target to 732 (764) pence - 'buy'

----------

FTSE 250

----------

UBS raises ITV price target to 80 (73) pence - 'neutral'

----------

Investec starts AO World with 'buy' - price target 130 pence

----------

JPMorgan cuts Victrex price target to 1,640 (1,680) pence - 'overweight'

----------

Deutsche Bank Research starts Future with 'buy' - price target 2,120 pence

----------

Deutsche Bank Research starts Auction Technology with 'buy' - price target 916 pence

----------

HSBC raises JD Wetherspoon price target to 1,030 (1,020) pence - 'buy'

----------

Barclays cuts Dr Martens price target to 80 (110) pence - 'equal weight'

----------

HSBC raises Elementis price target to 175 (170) pence - 'buy'

UBS raises Petershill Partners price target to 200 (175) pence - 'neutral'

----------

SMALL CAP

----------

Deutsche Bank Research starts GlobalData with 'hold' - price target 250 pence

----------

HSBC cuts TT Electronics price target to 270 (280) pence - 'buy'

----------

Barclays raises S4 Capital price target to 65 (50) pence - 'equal weight'

----------

HSBC starts Johnson Service with 'buy' - price target 210 pence

----------

Jefferies cuts SIG price target to 27.10 (27.80) pence - 'hold'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All rights reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
5678910111213

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.